• Patient-Derived Gastric Cancer Assembloids

  2026-09-25

  This study introduces patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal cell populations, bringing key features of the tumor microenvironment into an in vitro model. The authors show that stromal inclusion can reshape gene expression and drug sensitivity, supporting more context-aware preclinical testing while leaving clinical predictive value to be established.

• Doxorubicin Workflows for Cancer and Cardiac Screens

  2026-09-25

  Use Doxorubicin as a mechanism-informed reference for cancer-cell response assays and as a carefully interpreted perturbagen in iPSC-cardiomyocyte toxicity screens. This workflow connects dose and exposure design with high-content imaging, deep-learning phenotyping, and practical troubleshooting—without treating a cardiac signal as a measure of anticancer efficacy.

• Mosquito Xenobiotic Transport After Alizarin Exposure

  2026-09-24

  Kennel and Rouhier tested how three injected xenobiotics affect excretion and putative organic cation transporter expression in female Aedes aegypti. Their results point to a stronger effect of chemical structure on excreted material and mortality than on the measured transporter transcripts, while highlighting how much remains unknown about mosquito xenobiotic transport.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-24

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic signal that accumulates in tumor-associated macrophage lysosomes and promotes an AMPKα–STAT6–ARG1 program. The study connects cholesterol sensing to macrophage-mediated immune suppression and reports that targeting CH25H can improve antitumor responses, including with anti-PD-1 therapy.

• FAISL Stabilizes FAK to Drive TNBC Metastasis

  2026-09-23

  The study identifies FAISL, a long noncoding RNA, as a protein-level regulator of focal adhesion kinase (FAK): by binding FAK and limiting calpain 2 access, FAISL protects FAK from proteolysis and supports triple-negative breast cancer progression. Patient-tissue associations, cell experiments, and nanoparticle-mediated FAISL silencing in mouse models connect this mechanism to tumor growth and metastasis, while leaving its clinical applicability to be established.

• Lysosomal β-Galactosidase Staining Kit Workflow

  2026-09-23

  Use the Lysosomal β-Galactosidase Staining Kit to visualize acidic lysosomal activity as a brightfield control readout in cell and tissue workflows. Its polystyrene compatibility and precipitation-resistant formulation help separate genuine biology from handling artifacts, especially in senescence and cisplatin-resistance studies.

• Perphenazine: Reliable Cell Assay Workflows

  2026-09-22

  Perphenazine (SKU B6157) supports reproducible viability, mitochondrial-stress, and host-cell defense experiments when concentration, solvent, timing, and storage are controlled. This scenario-based guide translates receptor pharmacology and published phenothiazine evidence into practical decisions for biomedical researchers.

• 25-Hydroxycholesterol Reprograms TAM Immunity

  2026-09-22

  Xiao and colleagues identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint in tumor-associated macrophages. Their study connects lysosomal lipid sensing through GPR155–mTORC1 to AMPKα, STAT6 phosphorylation, ARG1 expression, and improved anti-PD-1 responses after CH25H targeting.

• SB525334: TGF-beta1 Receptor Inhibitor Workflows

  2026-09-21

  SB525334 enables selective interrogation of ALK5-driven TGF-beta signaling in fibrosis, renal disease, cancer, and wound-healing models. This guide translates the compound’s potency and mechanism into practical cell, tissue, and animal workflows while highlighting controls that distinguish pathway-specific effects from general toxicity.

• Cyanine 3 Tyramide for Reliable Cell Assays

  2026-09-21

  Learn how Cyanine 3 Tyramide (SKU K1085) can strengthen orthogonal fluorescence readouts when viability, proliferation, or cytotoxicity assays produce ambiguous results. This scenario-based guide covers TSA compatibility, preparation, interpretation, storage, and practical vendor-selection criteria.

• Perphenazine: D2 Antagonist Research Workflows

  2026-09-20

  Perphenazine combines dopamine D2 receptor antagonism with measurable mitochondrial and host-defense phenotypes, making it useful for both neuropharmacology and translational immunology workflows. This guide connects receptor profiling, mitochondria-mediated cell death induction, macrophage antibacterial assays, and practical troubleshooting while keeping cytotoxicity and pleiotropic signaling under control.

• Clozapine N-oxide (CNO) Assay Workflows

  2026-09-19

  A practical, evidence-based guide to using Clozapine N-oxide (CNO), SKU A3317, in chemogenetic and cell-based workflows. It addresses assay compatibility, stock preparation, control design, data interpretation, and product-selection criteria for more reproducible neuroscience research.

• Clozapine N-oxide (CNO) for Circuit Research

  2026-09-18

  Clozapine N-oxide (CNO) gives researchers reversible, cell-selective control of DREADD-expressing circuits without implanted stimulation hardware. This workflow-oriented guide shows how to use it alongside 40 Hz sensory entrainment assays to distinguish circuit necessity, sufficiency, and downstream effects in epilepsy and broader neuroscience research.

• EZ Cap™ EGFP mRNA: Assay Reliability

  2026-09-18

  Learn how EZ Cap™ EGFP mRNA (SKU R1002) can function as a controlled Cap 1 EGFP mRNA reporter input when delivery, viability, and cytotoxicity results are difficult to interpret. This scenario-based guide connects practical assay controls with published dendritic-cell electroporation findings while clearly separating evidence from workflow recommendations.

• Auditory Activity Sustains Neurogenesis and Cognition

  2026-09-17

  The reference study identifies a causal auditory-to-hippocampal pathway in which cochlear outer hair cell loss weakens PnCvGluT2 input to locus coeruleus norepinephrine neurons, reducing norepinephrine support for adult neurogenesis and cognition. Projection-specific stimulation restores both neurogenic and cognitive outcomes, providing a circuit-level explanation for how hearing loss can affect brain function.

812 records 6/55 page Previous Next First page 上5页 678910 下5页 Last page